Cumulative Patency Rate of Percutaneous Transluminal Angioplasty and Stent Placement for Aortoiliac Occlusive Disease.
- Author:
Dong Hyun CHOI
1
;
Sang Mok LEE
;
Suck Hwan KOH
;
Sung Wha HONG
;
Soo Myeong OH
;
Choong YOON
;
Ho Chul PARK
;
Ju Hyung OH
Author Information
1. Department of Surgery, Kyung-Hee University Hospital, Seoul, Korea. miumiup1@hotmail.com
- Publication Type:Original Article
- Keywords:
Iliac artery;
Angioplasty;
Stent;
Aortoiliac occlusive disease
- MeSH:
Angioplasty*;
Blue Toe Syndrome;
Diabetes Mellitus;
Femoral Artery;
Follow-Up Studies;
Humans;
Hyperlipidemias;
Hypertension;
Iliac Artery;
Renal Insufficiency;
Retrospective Studies;
Stents*;
Ultrasonography
- From:Journal of the Korean Society for Vascular Surgery
2004;20(1):70-77
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the results of iliac artery angioplasty and stent placement as an option for the treatment of aortoiliac occlusive disease. METHOD: The records of 30 patients (mean age, 65.5 years) who underwent iliac artery angioplasty and/or stent placement were reviewed retrospectively. Presenting symptoms included asymptomatic (6.7%), claudication (73.3%), rest pain (10%), ulceration/tissue loss (3.3%), and blue toe syndrome (6.7%). Follow-up included angioplasty, Doppler ultrasound, and clinical examination. Mean follow-up time was 32 months. RESULT: Forty iliac lesions were treated. Thirty-seven percent of patients had hypertension, 33% had diabetes mellitus, 23% had coronary arterial disease, 6.6% had cerebrovascular disease, 3.3% had hyperlipidemia and 3.3% had renal insufficiency. TASC (Trans Atlantic Inter-Society Consensus) A, B, C and D disease types were 11 (36.7%) patients, 5 (16.7%), 10 (33.3%) and 4 (13.3%). Ipsilateral superficial femoral artery occlusion was present in 6 (20%) patients. Concomitant femoral artery bypass surgery was performed in 10 (33.3%) patients. The cumulative primary patency rates were 83.4%, 71.9% and 64.7% at 1, 2, and 3 years, respectively. CONCLUSION: Iliac artery angioplasty and stent placement is a technically safe and effective treatment modality in patients without ipsilateral superficial femoral artery occlusion.
